GGrantIndex
← Leaderboards

Dolores Di Vizio

Boston Children'S Hospital

$4,501,193
Attributed
$6,590,097
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,590,097 · 7

By mechanism

R01$5,160,067 · 3
R00$722,337 · 1
R21$429,399 · 1
K99$273,294 · 1
R13$5,000 · 1

Top collaborators

Most similar at Boston Children'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsMalignant Neoplasm Of ProstateTumorCollaborationsPlayTumor ProgressionCancer CellMalignant - DescriptorExtracellular VesiclesSignal TransductionMolecularProgramsNeoplastic CellCancer PatientProteinsIn VivoVesicleGrowthSpecimenPlasmaSiteTumor-DerivedDisease ProgressionExosome

Grant awards (20)

Extracellular vesicle enclosed circular RNA and interferon responses in tumor host interactions.$429,399
R21 · FY2025 · CA · contact PI
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test$135,000
R01 · FY2025 · CA · contact PI
2025 RNA Nanotechnology Gordon Research Conference and Seminar$5,000
R13 · FY2025 · CA · contact PI
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test$649,486
R01 · FY2024 · CA · contact PI
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis$432,034
R01 · FY2023 · CA · contact PI
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis$446,785
R01 · FY2022 · CA · contact PI
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis$484,694
R01 · FY2021 · CA · contact PI
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer$325,459
R01 · FY2021 · CA · contact PI
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis$488,621
R01 · FY2020 · CA · contact PI
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer$347,533
R01 · FY2020 · CA · contact PI
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer$507,028
R01 · FY2019 · CA · contact PI
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis$496,626
R01 · FY2019 · CA · contact PI
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer$384,283
R01 · FY2018 · CA · contact PI
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer$462,518
R01 · FY2017 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$231,813
R00 · FY2012 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$201,551
R00 · FY2011 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$39,973
R00 · FY2011 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$249,000
R00 · FY2010 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$136,647
K99 · FY2009 · CA · contact PI
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer$136,647
K99 · FY2008 · CA · contact PI